Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website https://www.jocmr.org

Short Communication

Volume 12, Number 11, November 2020, pages 747-751


A Retrospective Study of Stromal Vascular Fraction Cell Therapy for Osteoarthritis

Tables

Table 1. Changes in Pain Levels After SVF Cell Therapy
 
Follow-up interval (n of evaluated subjects)Improvement, n (%)No change, n (%)Deterioration, n (%)
SVF: stromal vascular fraction.
7 days (345 subjects)156 (45.2%)180 (52.2%)9 (2.6%)
3 months (339 subjects)255 (75.3%)76 (22.4%)8 (2.3%)
6 months (346 subjects)292 (84.4%)46 (13.3%)8 (2.3%)
12 months (344 subjects)292 (84.9%)44 (12.8%)8 (2.3%)

 

Table 2. Changes in Mobility After SVF Cell Therapy
 
Follow-up interval (n of evaluated subjects)Improvement, n (%)No change, n (%)Deterioration, n (%)
SVF: stromal vascular fraction.
7 days (341 subjects)154 (45.2%)178 (52.2%)9 (2.6%)
3 months (342 subjects)257 (75.2%)77 (22.6%)7 (2.2%)
6 months (346 subjects)292 (84.4%)26 (13.3%)8 (2.3%)
12 months (344 subjects)292 (84.9%)44 (12.8%)8 (2.3%)

 

Table 3. Correlation of Measures of Treatment Efficacy With the Arthritis Stage
 
Measures of treatment efficacyArthritis classification (n of evaluated subjects)
I, I - II, II, II - III (216)III (57)III - IV, IV (77)
Improvement in pain, n (%)86 (39.8%)30 (52.6%)19 (24.7%)
Improvement in mobility, n (%)81 (37.5%)30 (52.6%)16 (20.7%)